QUANTIFYING THE MARKET POTENTIAL FOR A NEW PHARMACEUTICAL GRADE DIAGNOSTIC IMAGING AGENT

On December 4, 2014, In Case Studies, Tags
There is currently no industry standard database for Europe that identifies the location of PET/CT imaging sites and potential commercial cyclotron manufacturing sites. Unlike the US, the European market is fragmented with no true Pan-European manufacturing provider. As PET imaging technology transitions from a research-driven environment to a more commercially-driven one, much of this information is incomplete or not easily available for these markets.